Compare MYGN & CDZI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MYGN | CDZI |
|---|---|---|
| Founded | 1991 | 1983 |
| Country | United States | United States |
| Employees | N/A | 31 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Water Supply |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 413.8M |
| IPO Year | 1996 | N/A |
| Metric | MYGN | CDZI |
|---|---|---|
| Price | $4.28 | $3.83 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $7.64 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 800.2K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $771,400,000.00 | N/A |
| Revenue This Year | $6.86 | $12.97 |
| Revenue Next Year | $5.45 | $102.40 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $3.53 | $2.90 |
| 52 Week High | $8.59 | $6.96 |
| Indicator | MYGN | CDZI |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 38.67 |
| Support Level | $3.53 | $3.42 |
| Resistance Level | $5.30 | $5.12 |
| Average True Range (ATR) | 0.32 | 0.26 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 42.70 | 5.54 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Cadiz Inc is a water solutions provider, dedicated to delivering clean, reliable, and affordable water for people. It provides water solutions with a combination of land, water, pipeline, and water filtration assets located in Southern California between key water systems serving population centers in the Southwestern United States. The company operates in two reportable segments; Land and Water Resources segment, comprises all activities regarding its properties in the eastern Mojave Desert, pre-revenue development of the Mojave Groundwater Bank (supply, storage, and conveyance), and agricultural operations; and the Water Filtration Technology segment, generating maximum revenue engaged in providing water filtration solutions for impaired or contaminated groundwater sources.